Literature DB >> 27023865

Electrophysiology and metabolism of caveolin-3-overexpressing mice.

Jan M Schilling1,2, Yousuke T Horikawa3,4, Alice E Zemljic-Harpf1,2, Kevin P Vincent5, Leonid Tyan6, Judith K Yu2, Andrew D McCulloch5,7, Ravi C Balijepalli6, Hemal H Patel1,2, David M Roth8,9.   

Abstract

Caveolin-3 (Cav-3) plays a critical role in organizing signaling molecules and ion channels involved in cardiac conduction and metabolism. Mutations in Cav-3 are implicated in cardiac conduction abnormalities and myopathies. Additionally, cardiac-specific overexpression of Cav-3 (Cav-3 OE) is protective against ischemic and hypertensive injury, suggesting a potential role for Cav-3 in basal cardiac electrophysiology and metabolism involved in stress adaptation. We hypothesized that overexpression of Cav-3 may alter baseline cardiac conduction and metabolism. We examined: (1) ECG telemetry recordings at baseline and during pharmacological interventions, (2) ion channels involved in cardiac conduction with immunoblotting and computational modeling, and (3) baseline metabolism in Cav-3 OE and transgene-negative littermate control mice. Cav-3 OE mice had decreased heart rates, prolonged PR intervals, and shortened QTc intervals with no difference in activity compared to control mice. Dobutamine or propranolol did not cause significant changes between experimental groups in maximal (dobutamine) or minimal (propranolol) heart rate. Cav-3 OE mice had an overall lower chronotropic response to atropine. The expression of Kv1.4 and Kv4.3 channels, Nav1.5 channels, and connexin 43 were increased in Cav-3 OE mice. A computational model integrating the immunoblotting results indicated shortened action potential duration in Cav-3 OE mice linking the change in channel expression to the observed electrophysiology phenotype. Metabolic profiling showed no gross differences in VO2, VCO2, respiratory exchange ratio, heat generation, and feeding or drinking. In conclusion, Cav-3 OE mice have changes in ECG intervals, heart rates, and cardiac ion channel expression. These findings give novel mechanistic insights into previously reported Cav-3 dependent cardioprotection.

Entities:  

Keywords:  Cardiac conduction; Caveolae; Caveolin-3; Heart rate; Kv channels

Mesh:

Substances:

Year:  2016        PMID: 27023865      PMCID: PMC5336321          DOI: 10.1007/s00395-016-0542-9

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  66 in total

Review 1.  Functional consequences of abnormal Cx43 expression in the heart.

Authors:  Magda S C Fontes; Toon A B van Veen; Jacques M T de Bakker; Harold V M van Rijen
Journal:  Biochim Biophys Acta       Date:  2011-08-03

2.  Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.

Authors:  Yogananda S Markandeya; Laura J Phelan; Marites T Woon; Alexis M Keefe; Courtney R Reynolds; Benjamin K August; Timothy A Hacker; David M Roth; Hemal H Patel; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

Review 3.  Competitive sports and the heart: benefit or risk?

Authors:  Jürgen Scharhag; Herbert Löllgen; Wilfried Kindermann
Journal:  Dtsch Arztebl Int       Date:  2013-01-07       Impact factor: 5.594

4.  Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

Authors:  Yasuo M Tsutsumi; Rie Tsutsumi; Yousuke T Horikawa; Yoko Sakai; Eisuke Hamaguchi; Hiroshi Kitahata; Asuka Kasai; Noriko Kambe; Katsuya Tanaka
Journal:  J Anesth       Date:  2014-03-15       Impact factor: 2.078

5.  Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.

Authors:  Matteo Vatta; Michael J Ackerman; Bin Ye; Jonathan C Makielski; Enoh E Ughanze; Erica W Taylor; David J Tester; Ravi C Balijepalli; Jason D Foell; Zhaohui Li; Timothy J Kamp; Jeffrey A Towbin
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

6.  Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.

Authors:  Teng Zhang; Sandro L Yong; Xiao-Li Tian; Qing K Wang
Journal:  Biochem Biophys Res Commun       Date:  2007-02-07       Impact factor: 3.575

7.  Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Authors:  David Benoist; Rachel Stones; Mark Drinkhill; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

8.  Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker.

Authors:  Natalie J Chandler; Ian D Greener; James O Tellez; Shin Inada; Hanny Musa; Peter Molenaar; Dario Difrancesco; Mirko Baruscotti; Renato Longhi; Robert H Anderson; Rudolf Billeter; Vinod Sharma; Daniel C Sigg; Mark R Boyett; Halina Dobrzynski
Journal:  Circulation       Date:  2009-03-16       Impact factor: 29.690

9.  Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.

Authors:  Yasuo M Tsutsumi; Yousuke T Horikawa; Michelle M Jennings; Michael W Kidd; Ingrid R Niesman; Utako Yokoyama; Brian P Head; Yasuko Hagiwara; Yoshihiro Ishikawa; Atsushi Miyanohara; Piyush M Patel; Paul A Insel; Hemal H Patel; David M Roth
Journal:  Circulation       Date:  2008-10-20       Impact factor: 29.690

Review 10.  Basic mechanisms of cardiac impulse propagation and associated arrhythmias.

Authors:  André G Kléber; Yoram Rudy
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

View more
  9 in total

Review 1.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

2.  Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.

Authors:  So Yeon Kim; Kang Ho Kim; Jan M Schilling; Joseph Leem; Mehul Dhanani; Brian P Head; David M Roth; Alice E Zemljic-Harpf; Hemal H Patel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

Review 3.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Caveolin-3 is required for regulation of transient outward potassium current by angiotensin II in mouse atrial myocytes.

Authors:  Leonid Tyan; Daniel Turner; Karlie R Komp; Roman Y Medvedev; Evi Lim; Alexey V Glukhov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-08       Impact factor: 4.733

5.  Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits.

Authors:  Yasuhiro Ichikawa; Alice E Zemljic-Harpf; Zheng Zhang; M Dan McKirnan; Ana Maria Manso; Robert S Ross; H Kirk Hammond; Hemal H Patel; David M Roth
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

Review 6.  Species-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus.

Authors:  Andrew G Edwards; William E Louch
Journal:  Clin Med Insights Cardiol       Date:  2017-02-02

7.  Potential Roles of Serum Caveolin-3 Levels in Patients with Atrial Fibrillation.

Authors:  Ling-Yue Sun; Xiang Qu; Ling-Zhi Chen; Gao-Shu Zheng; Xin-Lei Wu; Xing-Xing Chen; Wei-Jian Huang; Hao Zhou
Journal:  Front Aging Neurosci       Date:  2017-04-04       Impact factor: 5.750

8.  Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia/reperfusion-induced Nav1.5 downregulation and ventricular arrhythmias.

Authors:  Chen-Chen Hu; Xin Wei; Jin-Min Liu; Lin-Lin Han; Cheng-Kun Xia; Jing Wu; Tao You; A-Fang Zhu; Shang-Long Yao; Shi-Ying Yuan; Hao-Dong Xu; Zheng-Yuan Xia; Ting-Ting Wang; Wei-Ke Mao
Journal:  Mil Med Res       Date:  2022-10-14

9.  Caveolin-1 facilitated KCNA5 expression, promoting breast cancer viability.

Authors:  Chao Qu; Jia Sun; Ying Liu; Xiaobo Wang; Lifen Wang; Chao Han; Qian Chen; Tianhui Guan; Hongyan Li; Yejun Zhang; Yang Wang; Jia Liu; Wei Zou; Jing Liu
Journal:  Oncol Lett       Date:  2018-08-03       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.